Product NDC: | 55390-308 |
Proprietary Name: | amifostine |
Non Proprietary Name: | amifostine |
Active Ingredient(s): | 500 mg/10mL & nbsp; amifostine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-308 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020221 |
Marketing Category: | NDA |
Start Marketing Date: | 20080402 |
Package NDC: | 55390-308-03 |
Package Description: | 3 VIAL, SINGLE-USE in 1 CARTON (55390-308-03) > 10 mL in 1 VIAL, SINGLE-USE |
NDC Code | 55390-308-03 |
Proprietary Name | amifostine |
Package Description | 3 VIAL, SINGLE-USE in 1 CARTON (55390-308-03) > 10 mL in 1 VIAL, SINGLE-USE |
Product NDC | 55390-308 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | amifostine |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20080402 |
Marketing Category Name | NDA |
Labeler Name | Bedford Laboratories |
Substance Name | AMIFOSTINE |
Strength Number | 500 |
Strength Unit | mg/10mL |
Pharmaceutical Classes | Cytoprotective Agent [EPC],Free Radical Scavenging Activity [MoA] |